research News

London, UK – Treatment of transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) with acoramidis may significantly improve the 4-step primary hierarchical outcome containing components of mortality, morbidity, and function, with similar safety as placebo, according to an article published in The New England Journal of Medicine. “Acoramidis is a high-affinity TTR stabilizer that acts...
Tucson, Arizona – A recent breakthrough study from the lab of Tanya Kalin, MD, PhD, professor of Child Health and Internal Medicine at the University of Arizona College of Medicine – Phoenix, has shown potential to improve therapeutic outcomes for patients suffering from lung cancers. “We have identified the novel protein FOXF1 that...